- ISIN
- US04963C2098
- CUSIP
- 04963C209
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- IPO Date
- Aug 5, 2005
Highlights
- Market Cap
- $1.39B
- Enterprise Value
- $1.32B
- EPS (TTM)
- -$0.10
- Total Revenue (TTM)
- $552.16M
- Gross Profit (TTM)
- $416.70M
- EBITDA (TTM)
- $18.22M
- Year Range
- $25.36 - $43.18
- Target Price
- $50.67
- ROA (TTM)
- -0.71%
- ROE (TTM)
- -0.93%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
ATRC Performance Chart
AtriCure, Inc. (ATRC) is down 28.1% since the beginning of the year. At $28 per share, ATRC is trading 34.1% below its 52-week high of $43. Investors who bought $1,000 worth of ATRC shares 5 years ago would now be looking at an investment worth $367.
Loading charts...
Returns By Period
AtriCure, Inc. (ATRC) has returned -28.11% so far this year and -9.43% over the past 12 months. Over the last ten years, ATRC has returned 7.00% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
AtriCure, Inc.
- 1D
- -1.25%
- 1M
- 0.53%
- YTD
- -28.11%
- 6M
- -31.72%
- 1Y
- -9.43%
- 3Y*
- -15.93%
- 5Y*
- -18.16%
- 10Y*
- 7.00%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
ATRC Monthly Returns History
Based on dividend-adjusted daily data since Aug 5, 2005, ATRC's average daily return is +0.08%, while the average monthly return is +1.40%. At this rate, an investment would double in approximately 4.2 years.
Historically, 56% of months were positive and 44% were negative. The best month was May 2009 with a return of +98.4%, while the worst month was Nov 2008 at -61.5%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 8 months.
On a daily basis, ATRC closed higher 50% of trading days. The best single day was May 5, 2009 with a return of +125.7%, while the worst single day was Nov 3, 2008 at -39.4%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -6.65% | -15.35% | -8.73% | -1.47% | -1.57% | 2.78% | -28.11% | ||||||
| 2025 | 30.46% | -2.83% | -16.73% | -7.28% | 15.58% | -5.21% | 7.11% | 5.38% | -4.70% | -1.99% | 4.54% | 9.52% | 29.45% |
| 2024 | -4.57% | 2.67% | -13.01% | -20.71% | -6.55% | 1.02% | -5.27% | 21.51% | 6.98% | 18.33% | 8.98% | -15.49% | -14.37% |
| 2023 | -2.48% | -11.04% | 7.66% | 6.13% | 2.23% | 9.76% | 12.14% | -18.43% | -2.99% | -20.91% | 2.42% | 0.59% | -19.58% |
| 2022 | -5.59% | 5.80% | -5.44% | -20.92% | -21.76% | 0.57% | 20.93% | -7.67% | -14.29% | 7.72% | 8.17% | -2.59% | -36.17% |
| 2021 | 4.60% | 12.09% | 0.38% | 17.63% | -3.04% | 6.16% | 6.47% | -12.83% | -5.53% | 7.92% | -15.53% | 9.67% | 24.90% |
Benchmark Metrics
AtriCure, Inc. has an annualized alpha of 11.69%, beta of 0.78, and R2 of 0.07 versus S&P 500 Index. Calculated based on daily prices since August 05, 2005.
- This stock participated in 132.23% of S&P 500 Index downside but only 113.83% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.07 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 11.69%
- Beta
- 0.78
- R²
- 0.07
- Upside Capture
- 113.83%
- Downside Capture
- 132.23%
Return for Risk
Risk / Return Rank
ATRC ranks 33 for risk / return — below 33% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for AtriCure, Inc. (ATRC) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ATRC | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.24 | ||
| Sortino ratioReturn per unit of downside risk | -2.74 | ||
| Omega ratioGain probability vs. loss probability | 1.00 | 1.37 | -0.37 |
| Calmar ratioReturn relative to maximum drawdown | -0.24 | 2.78 | -3.03 |
| Martin ratioReturn relative to average drawdown | -0.48 | 12.44 | -12.91 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the AtriCure, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the AtriCure, Inc. was 92.84%, occurring on Apr 24, 2009. Recovery took 1149 trading sessions.
The current AtriCure, Inc. drawdown is 67.36%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
Financial crisis2007–2009 | -92.84%Apr 2009 | 3y 8mo | 4y 6mo | 8y 3moAug 2005 - Nov 2013 |
2024 bear market2024 | -77.21%Jun 2024 | 2y 7mo | — | 4y 7moNov 2021 - now |
2016 bear market2016 | -51.52%Aug 2016 | 1y 2d | 1y 10mo | 2y 10moAug 2015 - Jun 2018 |
COVID crash2020 | -44.14%Mar 2020 | 29d | 1mo 21d | 2mo 20dFeb 2020 - May 2020 |
2014 bear market2014 | -38.50%Oct 2014 | 8mo 17d | 6mo 26d | 1y 3moJan 2014 - May 2015 |
Drawdown Indicators
| ATRC | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.84% | -56.78% | -36.06% |
Max Drawdown (1Y)Largest decline over 1 year | -39.02% | -9.10% | -29.92% |
Max Drawdown (3Y)Largest decline over 3 years | -65.60% | -18.90% | -46.70% |
Max Drawdown (5Y)Largest decline over 5 years | -77.21% | -25.43% | -51.78% |
Max Drawdown (10Y)Largest decline over 10 years | -77.21% | -33.92% | -43.29% |
Current DrawdownCurrent decline from peak | -67.36% | -1.80% | -65.56% |
Average DrawdownAverage peak-to-trough decline | -36.03% | -10.71% | -25.32% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 19.88% | 2.03% | +17.85% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of AtriCure, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how AtriCure, Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ATRC relative to other companies in the Medical Instruments & Supplies industry. Currently, ATRC has a P/S ratio of 2.5. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ATRC in comparison with other companies in the Medical Instruments & Supplies industry. Currently, ATRC has a P/B value of 2.8. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with ATRC
Add AtriCure, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with ATRC